1. Home
  2. NVAX vs DRH Comparison

NVAX vs DRH Comparison

Compare NVAX & DRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • DRH
  • Stock Information
  • Founded
  • NVAX 1987
  • DRH 2004
  • Country
  • NVAX United States
  • DRH United States
  • Employees
  • NVAX N/A
  • DRH N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • DRH Real Estate Investment Trusts
  • Sector
  • NVAX Health Care
  • DRH Real Estate
  • Exchange
  • NVAX Nasdaq
  • DRH Nasdaq
  • Market Cap
  • NVAX 1.3B
  • DRH 1.6B
  • IPO Year
  • NVAX 1995
  • DRH 2005
  • Fundamental
  • Price
  • NVAX $6.56
  • DRH $7.56
  • Analyst Decision
  • NVAX Buy
  • DRH Hold
  • Analyst Count
  • NVAX 6
  • DRH 7
  • Target Price
  • NVAX $15.33
  • DRH $8.71
  • AVG Volume (30 Days)
  • NVAX 5.1M
  • DRH 2.8M
  • Earning Date
  • NVAX 08-06-2025
  • DRH 08-07-2025
  • Dividend Yield
  • NVAX N/A
  • DRH 4.23%
  • EPS Growth
  • NVAX N/A
  • DRH N/A
  • EPS
  • NVAX 2.97
  • DRH 0.19
  • Revenue
  • NVAX $1,254,962,000.00
  • DRH $1,128,313,000.00
  • Revenue This Year
  • NVAX $52.02
  • DRH N/A
  • Revenue Next Year
  • NVAX N/A
  • DRH $2.32
  • P/E Ratio
  • NVAX $2.21
  • DRH $39.82
  • Revenue Growth
  • NVAX 25.92
  • DRH 3.73
  • 52 Week Low
  • NVAX $5.01
  • DRH $6.19
  • 52 Week High
  • NVAX $15.22
  • DRH $10.00
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 40.82
  • DRH 36.50
  • Support Level
  • NVAX $6.93
  • DRH $7.86
  • Resistance Level
  • NVAX $8.46
  • DRH $8.17
  • Average True Range (ATR)
  • NVAX 0.34
  • DRH 0.18
  • MACD
  • NVAX -0.08
  • DRH -0.06
  • Stochastic Oscillator
  • NVAX 9.52
  • DRH 7.88

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About DRH Diamondrock Hospitality Company

Diamondrock Hospitality Company is a real estate investment trust that owns lodging properties. Its business is to acquire, own, manage, and renovate full-service hotel properties in the United States. It operates in cities such as Chicago, Boston, New York, Denver, and others. Within DiamondRock's holdings, the majority of the hotel brands include Marriott, Starwood, and Hilton. The revenue is divided between room, food and beverage, and others. The room segment contributes the majority of the revenue. The firm's customers include leisure transients, business transients, and group customers.

Share on Social Networks: